Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Testosterone Enanthate + Undecanoate In The Dosage Form Ilo

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  MT Ref Id - 90039442

  Document Type - Tender Notices

Description - Description: Section 130a Para. 8 SGB V enables health insurance companies (KK) and pharmaceutical companies to conclude framework discount agreements for the drugs dispensed at the expense of the statutory health insurance companies. The GWQ acts as a company for efficiency and quality in KK in accordance with Section 130a Para. 8 Sentence 5 SGBV for its shareholder and customer funds. With regard to the relevant legal provisions for the award of public contracts, a regular process of active ingredient-related, formal award procedures takes place in accordance with the regulations of Part 4 of the GWB by the GWQ ServicePlus AG. By the time new drug discount agreements come into force, the G

Mt Ref Id - 90039442

Deadline - May 10, 2026